Dr. Vogel shared insights on the importance of liver function in treatment decisions, the significance of treatment intent, and the potential of immunotherapy as a downstaging or bridging strategy for liver transplantation. With a wealth of experience, he emphasized the need for careful consideration of patient-specific factors and the management of treatment-related toxicities.